Delivery Order SPE2DB22D3016-SPE2DB24FBHF8

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order (SPE2DB20D2014|SPE2DB25FB94M) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,235,218 units of 200 mg/20 ml ketamine vials. The $1,773.46 firm fixed-price contract has a completion date of May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.85, is a Firm Fixed Price Delivery Order for the delivery of 500 mg/5 ml vials of the drug Ketamine. The contract has a period of performance through November 19, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any specific business category....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4563925171 - Ketamine 200 mg/20 ml vial, 20 ml, with a firm fixed price of $3,957.60 and a performance period through March 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 mg/20 ml vials of the drug Ketamine. The contract has a firm fixed price of $1,105.04 and a period of performance ending on June 24, 2025. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 200 mg/20 ml vials of the drug ketamine, with a ceiling value of $1,493.10 and a performance period extending through June 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566631897 - Ketamine 200 mg/20 ml vials. The $3,595.73 firm fixed-price delivery order has a completion date of December 9, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,610.28 delivery order is for the supply of 4,565,057,473 units of 500 mg/5 ml ketamine vials. The contract has a final completion date of July 3, 2024 and utilizes a firm fixed price pricing structure. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059 firm-fixed-price delivery order is for the supply of 4,566,134,691 units of Ketamine 500 mg/5 ml vials. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $4,101.80 by the Defense Logistics Agency (DLA) to provide 4,563,567,182 units of 200 mg/20 ml Ketamine vials. The contract has a completion date of February 7, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the provision of 4564893432 Ketamine HCL 20ML 10S, a pharmaceutical product, to the U.S. government. The contract, awarded by the Medical Supply Chain unit of the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $2,105.55 and a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBHF8
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Ketamine 200mg/20ml vials to the agency. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for a ceiling value of $1,382.08. The contract has a final completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/19/24, 9:13 AM